Validation of Current Good Manufacturing Practice Compliant Human Pluripotent Stem Cell‐Derived Hepatocytes for Cell‐Based Therapy

Recent advancements in the production of hepatocytes from human pluripotent stem cells (hPSC‐Heps) afford tremendous possibilities for treatment of patients with liver disease. Validated current good manufacturing practice (cGMP) lines are an essential prerequisite for such applications but have onl...

Descripción completa

Detalles Bibliográficos
Autores principales: Blackford, Samuel J.I., Ng, Soon Seng, Segal, Joe M., King, Aileen J.F., Austin, Amazon L., Kent, Deniz, Moore, Jennifer, Sheldon, Michael, Ilic, Dusko, Dhawan, Anil, Mitry, Ragai R., Rashid, S. Tamir
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley & Sons, Inc. 2018
Materias:
Pluripotent Stem Cells
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6344902/
https://www.ncbi.nlm.nih.gov/pubmed/30456803
http://dx.doi.org/10.1002/sctm.18-0084

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6344902/
https://www.ncbi.nlm.nih.gov/pubmed/30456803
http://dx.doi.org/10.1002/sctm.18-0084

Ejemplares similares